Fscn1 inhibitors developed for tumor therapy attenuate the T cell stimulatory activity of dendritic cells Y. Zeyn,G. Harms, I. Tubbe,E. Montermann,N. Roehrig, M. Hartmann,S. Grabbe,M. BrosEUROPEAN JOURNAL OF IMMUNOLOGY(2022)引用 0|浏览10暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要